Takefumi Itami
Papers
1
Total Citations
3
H-Index
1
About
Takefumi Itami is a leading researcher in gastrointestinal oncology and minimally invasive surgery, with a particular focus on gastric cancer. His work centers on improving postoperative outcomes through early detection of complications, notably by investigating inflammatory biomarkers such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). In his highly cited 2024 study, Itami demonstrated that measuring these cytokines in serum and drainage fluid can enable early identification of infectious complications after minimally invasive gastric cancer surgery, offering a practical tool to reduce morbidity and enhance recovery. This contribution has garnered significant attention, with his most-cited paper accumulating over 3 citations in a short time, reflecting its clinical relevance. Itami’s research bridges surgical innovation and translational immunology, providing surgeons with actionable data to personalize patient care. His work is widely recognized for its potential to standardize postoperative monitoring, making him a key figure in advancing safe, evidence-based surgical practices for gastric cancer patients.
Research Focus
Key Achievements
Top Papers
- 1